IMP
Process View
skeletal muscle satellite cell proliferation
The multiplication or reproduction of satellite cells, resulting in the expansion of the cell population. Satellite cells are quiescent cells that are located between the basal lamina and the plasmalemma of the muscle fiber, which are the main contributors to postnatal muscle growth. In adult muscle, satellite cells become activated to divide and differentiate in response to muscle damage.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "skeletal muscle satellite cell proliferation"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| CASP8 | caspase 8, apoptosis-related cysteine peptidase | 1.000 | ||
| TEK | TEK tyrosine kinase, endothelial | 1.000 | ||
| CASP10 | caspase 10, apoptosis-related cysteine peptidase | 1.000 | ||
| TNFRSF10A | tumor necrosis factor receptor superfamily, member 10a | 0.998 | ||
| FADD | Fas (TNFRSF6)-associated via death domain | 0.997 | ||
| FGA | fibrinogen alpha chain | 0.997 | ||
| FAS | Fas (TNF receptor superfamily, member 6) | 0.993 | ||
| TNFRSF10B | tumor necrosis factor receptor superfamily, member 10b | 0.962 | ||
| TNFSF10 | tumor necrosis factor (ligand) superfamily, member 10 | 0.931 | ||
| RIPK1 | receptor (TNFRSF)-interacting serine-threonine kinase 1 | 0.822 | ||
| FGG | fibrinogen gamma chain | 0.813 | ||
| FASLG | Fas ligand (TNF superfamily, member 6) | 0.810 | ||
| TRAF1 | TNF receptor-associated factor 1 | 0.432 | ||
| SRF | serum response factor (c-fos serum response element-binding transcription factor) | 0.335 | ||
| ANGPT2 | angiopoietin 2 | 0.299 | Human | |
| ANGPT1 | angiopoietin 1 | 0.275 | ||
| DPT | dermatopontin | 0.207 | ||
| CBLB | Cas-Br-M (murine) ecotropic retroviral transforming sequence b | 0.202 | ||
| GRB7 | growth factor receptor-bound protein 7 | 0.133 | ||
| CD163 | CD163 molecule | 0.111 | ||
| TIE1 | tyrosine kinase with immunoglobulin-like and EGF-like domains 1 | 0.100 | ||
| NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | 0.081 | ||
| CDH5 | cadherin 5, type 2 (vascular endothelium) | 0.074 | ||
| DCN | decorin | 0.072 | ||
| NFKBIZ | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta | 0.066 | ||
| TRAF3 | TNF receptor-associated factor 3 | 0.066 | ||
| JAK1 | Janus kinase 1 | 0.064 | ||
| MDFI | MyoD family inhibitor | 0.062 | ||
| PIK3R3 | phosphoinositide-3-kinase, regulatory subunit 3 (gamma) | 0.058 | ||
| TRIM43 | tripartite motif containing 43 | 0.048 | ||
| ENTPD1 | ectonucleoside triphosphate diphosphohydrolase 1 | 0.037 | ||
| FYN | FYN oncogene related to SRC, FGR, YES | 0.037 | ||
| HIVEP1 | human immunodeficiency virus type I enhancer binding protein 1 | 0.035 | ||
| CAPN1 | calpain 1, (mu/I) large subunit | 0.031 | ||
| MAP3K14 | mitogen-activated protein kinase kinase kinase 14 | 0.031 | ||
| FBN1 | fibrillin 1 | 0.031 | ||
| F2 | coagulation factor II (thrombin) | 0.030 | ||
| APOA1 | apolipoprotein A-I | 0.029 | ||
| PDE4DIP | phosphodiesterase 4D interacting protein | 0.027 | ||
| EYA2 | eyes absent homolog 2 (Drosophila) | 0.025 | ||
| HOXD8 | homeobox D8 | 0.024 | ||
| CCDC85B | coiled-coil domain containing 85B | 0.022 | ||
| LPA | lipoprotein, Lp(a) | 0.022 | ||
| SRL | sarcalumenin | 0.021 | ||
| ALB | albumin | 0.021 | ||
| CEBPB | CCAAT/enhancer binding protein (C/EBP), beta | 0.020 | ||
| CD2AP | CD2-associated protein | 0.020 | ||
| AQP1 | aquaporin 1 (Colton blood group) | 0.020 | ||
| STC1 | stanniocalcin 1 | 0.019 | ||
| EVI2A | ecotropic viral integration site 2A | 0.018 | ||
| TNNI1 | troponin I type 1 (skeletal, slow) | 0.017 | ||
| TNFRSF1A | tumor necrosis factor receptor superfamily, member 1A | 0.017 | ||
| C1R | complement component 1, r subcomponent | 0.017 | ||
| FCGR2B | Fc fragment of IgG, low affinity IIb, receptor (CD32) | 0.017 | ||
| GUCY1A3 | guanylate cyclase 1, soluble, alpha 3 | 0.017 | ||
| GJA4 | gap junction protein, alpha 4, 37kDa | 0.017 | ||
| CCNK | cyclin K | 0.016 | ||
| CCND2 | cyclin D2 | 0.016 | ||
| IGFBP5 | insulin-like growth factor binding protein 5 | 0.016 | ||
| TAF6L | TAF6-like RNA polymerase II, p300/CBP-associated factor (PCAF)-associated factor, 65kDa | 0.016 | ||
| TRIM32 | tripartite motif containing 32 | 0.016 | ||
| SSPN | sarcospan (Kras oncogene-associated gene) | 0.015 | ||
| FAM46A | family with sequence similarity 46, member A | 0.015 | ||
| F10 | coagulation factor X | 0.015 | ||
| MKL1 | megakaryoblastic leukemia (translocation) 1 | 0.015 | ||
| BCL3 | B-cell CLL/lymphoma 3 | 0.015 | ||
| LHB | luteinizing hormone beta polypeptide | 0.015 | ||
| DEDD | death effector domain containing | 0.014 | ||
| MSR1 | macrophage scavenger receptor 1 | 0.014 | ||
| CCND1 | cyclin D1 | 0.014 | ||
| CCND3 | cyclin D3 | 0.014 | ||
| OGN | osteoglycin | 0.014 | ||
| ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.014 | ||
| C3 | complement component 3 | 0.013 | ||
| GRRP1 | glycine/arginine rich protein 1 | 0.013 | ||
| APLN | apelin | 0.013 | ||
| VTN | vitronectin | 0.013 | ||
| VSIG4 | V-set and immunoglobulin domain containing 4 | 0.013 | ||
| SULT2A1 | sulfotransferase family, cytosolic, 2A, dehydroepiandrosterone (DHEA)-preferring, member 1 | 0.013 | ||
| IL18R1 | interleukin 18 receptor 1 | 0.012 | ||
| CALCRL | calcitonin receptor-like | 0.012 | ||
| MGP | matrix Gla protein | 0.012 | ||
| MRGPRF | MAS-related GPR, member F | 0.012 | ||
| BGN | biglycan | 0.012 | ||
| SNED1 | sushi, nidogen and EGF-like domains 1 | 0.012 | ||
| TBC1D5 | TBC1 domain family, member 5 | 0.012 | ||
| ZHX3 | zinc fingers and homeoboxes 3 | 0.012 | ||
| NOS3 | nitric oxide synthase 3 (endothelial cell) | 0.012 | ||
| SGCD | sarcoglycan, delta (35kDa dystrophin-associated glycoprotein) | 0.012 | ||
| RND1 | Rho family GTPase 1 | 0.012 | ||
| SFRP2 | secreted frizzled-related protein 2 | 0.012 | ||
| ACTA1 | actin, alpha 1, skeletal muscle | 0.012 | ||
| DOCK7 | dedicator of cytokinesis 7 | 0.012 | ||
| GPT | glutamic-pyruvate transaminase (alanine aminotransferase) | 0.011 | ||
| TMSB4X | thymosin beta 4, X-linked | 0.011 | ||
| MAP2K1 | mitogen-activated protein kinase kinase 1 | 0.011 | ||
| TNNC1 | troponin C type 1 (slow) | 0.011 | ||
| MYLPF | myosin light chain, phosphorylatable, fast skeletal muscle | 0.011 | ||
| SERPINA3 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3 | 0.011 | ||
| MLL4 | myeloid/lymphoid or mixed-lineage leukemia 4 | 0.011 | ||
| MYBPH | myosin binding protein H | 0.011 | ||
| DYNC1I1 | dynein, cytoplasmic 1, intermediate chain 1 | 0.011 | ||
| CDH18 | cadherin 18, type 2 | 0.011 | ||
| RANBP10 | RAN binding protein 10 | 0.011 | ||
| CST1 | cystatin SN | 0.011 | ||
| CD36 | CD36 molecule (thrombospondin receptor) | 0.011 | ||
| MORC4 | MORC family CW-type zinc finger 4 | 0.011 | ||
| PROC | protein C (inactivator of coagulation factors Va and VIIIa) | 0.011 | ||
| LBP | lipopolysaccharide binding protein | 0.011 | ||
| SPINK1 | serine peptidase inhibitor, Kazal type 1 | 0.011 | ||
| COL5A1 | collagen, type V, alpha 1 | 0.011 | ||
| IL6R | interleukin 6 receptor | 0.011 | ||
| C1orf54 | chromosome 1 open reading frame 54 | 0.010 | ||
| IL6ST | interleukin 6 signal transducer (gp130, oncostatin M receptor) | 0.010 | ||
| FOLR2 | folate receptor 2 (fetal) | 0.010 | ||
| ALPK3 | alpha-kinase 3 | 0.010 | ||
| SOD2 | superoxide dismutase 2, mitochondrial | 0.010 |